retatrutide for diabetes type 2 Effects of on body composition in people with diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial Retatrutide – The New Weight

Recuperato da: Chen W, Cai P, Zou W, Fu Z

Fatty liver disease is one of the most common complications of obesity and this level of reduction is clinically meaningful

Any history of alcohol-related health problems , including liver disease, pancreatitis, gastritis, or previous attempts to reduce drinking Changes in drinking patterns since starting GLP-1 medication, whether increased or decreased consumption, or altered tolerance to alcohol Gastrointestinal symptoms and whether alcohol worsens nausea, vomiting, or other side effects Concerns about alcohol use disorder : If you're finding it difficult to control your drinking, your GP can arrange referral to specialist NHS alcohol services Your GP should provide personalised advice based on your individual circumstances, including other medications, comorbidities, and treatment goals

Why do people lose muscle on GLP-1 medications

This is the question most people avoid asking until they are already on the drug

Semaglutide is a GLP-1 receptor agonist initially developed as a medication for diabetes